In a mouse lymphoma model, Gilbert et al. showed that TIMP-1 was released in the thymus in response to chemotherapy-induced DNA damage, creating a “chemo-resistant niche” that promoted the survival of minimal residual tumor cells and served as a reservoir for eventual tumor relapse [157]. Here, TIMP1 is linked to neoplasm.